Zobrazeno 1 - 10
of 275
pro vyhledávání: '"J C, Brouet"'
Autor:
Jean-Claude Rambaud, Jacques Cosnes, F. Carbonnel, Benoit Coffin, H d'Almagne, J C Brouet, J Nemeth, Anne Lavergne, C Matuchansky, F Sigaux, Jean-Pierre Gendre, Laurent Beaugerie
Publikováno v:
Gut. 45:662-667
METHODS—Four patients with clinicopathological features suggesting a new distinct entity defining extensive small intestinal CD4 T cell infiltration were observed. RESULTS—All four patients presented with chronic diarrhoea, malabsorption, and wei
Autor:
J.-C. Brouet
Publikováno v:
EMC - Traité de médecine AKOS. 1:1-3
Autor:
J.-C. Brouet
Publikováno v:
Revue Française des Laboratoires. 1998:49-51
Autor:
J C, Brouet
Publikováno v:
La Revue du praticien. 51(20)
Publikováno v:
European journal of immunology. 30(9)
We evaluated the B cell memory pool among blood B cells from 20 patients with common variable immunodeficiency (CVID). CD27+ B cell number was normal or increased in 6 patients (with 95% CD27+ B cells in 1 patient) and decreased in 14 patients. In 13
Publikováno v:
British journal of haematology. 106(1)
We report four patients with Waldenström's macroglobulinaemia with an unusual neurologic complication, neurolymphomatosis, characterized by meningeal and root nerve infiltration by lymphoplasmacytic cells. Patients presented with rapidly progressive
Autor:
X, Mariette, A M, Zagdanski, A, Guermazi, C, Bergot, A, Arnould, J, Frija, J C, Brouet, J P, Fermand
Publikováno v:
British journal of haematology. 104(4)
We assessed the role of spinal magnetic resonance imaging (MRI) and bone densitometry as prognostic factors in patients with asymptomatic stage I multiple myeloma (MM) and negative skeletal survey. 55 consecutive patients underwent spinal MRI and 41
Autor:
P, Rousselot, S, Labaume, J P, Marolleau, J, Larghero, M H, Noguera, J C, Brouet, J P, Fermand
Publikováno v:
Cancer research. 59(5)
Recent data have renewed the interest for arsenic-containing compounds as anticancer agents. In particular, arsenic trioxide (As2O3) has been demonstrated to be an effective drug in the treatment of acute promyelocytic leukemia by inducing programmed
Publikováno v:
Leukemialymphoma. 30(3-4)
The effects of all trans retinoic acid (ATRA) on human myeloma cells growth were studied in vitro and in vivo using immunodeficient mice engrafted with malignant plasma cells. ATRA inhibited the in vitro proliferation of plasma cells originating from
Publikováno v:
Blood. 91(11)